Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc and Clobetasol for Regorafenib-Induced HFSR
NCT06856590Completed
- Sponsor
- Gazi University
- Start
- Feb 2025
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of clobetasol and zinc gluconate in Hand-foot skin reaction (HFSR) (3 arms), sponsored by Gazi University. Primary endpoint: Incidence and Severity of Hand-Foot Skin Reaction (HFSR) at Week 8. Started Feb 2025; status: completed.
02
Drugs
clobetasolzinc gluconate
03
Conditions
Hand-foot skin reaction (HFSR)
Beyond the preview
Go deeper on NCT06856590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06856590.